159 related articles for article (PubMed ID: 37722356)
21. Bendamustine for the treatment of chronic lymphocytic leukemia and rituximab-refractory, indolent B-cell non-Hodgkin lymphoma.
Dennie TW; Kolesar JM
Clin Ther; 2009; 31 Pt 2():2290-311. PubMed ID: 20110042
[TBL] [Abstract][Full Text] [Related]
22. Explainable machine learning for chronic lymphocytic leukemia treatment prediction using only inexpensive tests.
Meiseles A; Paley D; Ziv M; Hadid Y; Rokach L; Tadmor T
Comput Biol Med; 2022 Jun; 145():105490. PubMed ID: 35405402
[TBL] [Abstract][Full Text] [Related]
23. The patient experience of patient-centered communication with nurses in the hospital setting: a qualitative systematic review protocol.
Newell S; Jordan Z
JBI Database System Rev Implement Rep; 2015 Jan; 13(1):76-87. PubMed ID: 26447009
[TBL] [Abstract][Full Text] [Related]
24. Health-related quality of life and treatment satisfaction in Chronic Lymphocytic Leukemia (CLL) patients on ibrutinib compared to other CLL treatments in a real-world US cross sectional study.
Deering KL; Sundaram M; Harshaw Q; Trudeau J; Barrientos JC
PLoS One; 2022; 17(10):e0270291. PubMed ID: 36201482
[TBL] [Abstract][Full Text] [Related]
25. Real-world analysis of treatment patterns and clinical outcomes in patients with newly diagnosed chronic lymphocytic leukemia from seven Latin American countries.
Chiattone C; Gomez-Almaguer D; Pavlovsky C; Tuna-Aguilar EJ; Basquiera AL; Palmer L; de Farias DLC; da Silva Araujo SS; Galvez-Cardenas KM; Gomez Diaz A; Lin JH; Chen YW; Machnicki G; Mahler M; Parisi L; Barreyro P
Hematology; 2020 Dec; 25(1):366-371. PubMed ID: 33095117
[TBL] [Abstract][Full Text] [Related]
26. Spotlight on chronic lymphocytic leukemia: a Pharma Matters report.
D'Souza P; Walker G
Drugs Today (Barc); 2014 Jul; 50(7):485-501. PubMed ID: 25101331
[TBL] [Abstract][Full Text] [Related]
27. Diagnosis, treatment and supportive management of chronic lymphocytic leukemia: recommendations of the Dutch HOVON CLL working group.
Raa DGT; van der Straten L; van Gelder M; Kersting S; Levin MD; Mous R; van der Straaten HM; Nijziel MR; van der Spek E; Posthuma EFM; Visser HPJ; van der Klift M; de Heer K; Bellido M; Doorduijn JK; Bruns AHW; Raijmakers RAP; Kater AP;
Leuk Lymphoma; 2022 Oct; 63(10):2276-2289. PubMed ID: 35737364
[TBL] [Abstract][Full Text] [Related]
28. Managing the Risk of Infection in Chronic Lymphocytic Leukemia in the Era of New Therapies.
Rivera D; Ferrajoli A
Curr Oncol Rep; 2022 Aug; 24(8):1003-1014. PubMed ID: 35366167
[TBL] [Abstract][Full Text] [Related]
29. COVID-19 and Chronic Lymphocytic Leukemia: Where We Stand Now.
Chatzikonstantinou T; Herishanu Y; Montserrat E; Ghia P; Cuneo A; Foà R; Scarfò L
Cancer J; 2021 Jul-Aug 01; 27(4):328-333. PubMed ID: 34398560
[TBL] [Abstract][Full Text] [Related]
30. Frontline Treatment for Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL): Targeted Therapy vs. Chemoimmunotherapy.
Small S; Ma S
Curr Hematol Malig Rep; 2021 Aug; 16(4):325-335. PubMed ID: 34021874
[TBL] [Abstract][Full Text] [Related]
31. Chronic Lymphocytic Leukemia in the SARS-CoV-2 Pandemic.
Arellano-Llamas AA; Vela-Ojeda J; Hernandez-Caballero A
Curr Oncol Rep; 2022 Feb; 24(2):209-213. PubMed ID: 35061199
[TBL] [Abstract][Full Text] [Related]
32. Effects of the BTN162b2 mRNA COVID-19 vaccine in humoral and cellular immunity in patients with chronic lymphocytic leukemia.
Fiorcari S; Atene CG; Maffei R; Mesini N; Debbia G; Colasante C; Pozzi S; Barbieri E; Maccaferri M; Leonardi G; Potenza L; Luppi M; Marasca R
Hematol Oncol; 2023 Feb; 41(1):120-127. PubMed ID: 36156278
[TBL] [Abstract][Full Text] [Related]
33. What Is Optimal Front-Line Therapy for Chronic Lymphocytic Leukemia in 2017?
Voorhies BN; Stephens DM
Curr Treat Options Oncol; 2017 Feb; 18(2):12. PubMed ID: 28243993
[TBL] [Abstract][Full Text] [Related]
34. Chemoimmunotherapy for relapsed/refractory and progressive 17p13-deleted chronic lymphocytic leukemia (CLL) combining pentostatin, alemtuzumab, and low-dose rituximab is effective and tolerable and limits loss of CD20 expression by circulating CLL cells.
Zent CS; Taylor RP; Lindorfer MA; Beum PV; LaPlant B; Wu W; Call TG; Bowen DA; Conte MJ; Frederick LA; Link BK; Blackwell SE; Veeramani S; Baig NA; Viswanatha DS; Weiner GJ; Witzig TE
Am J Hematol; 2014 Jul; 89(7):757-65. PubMed ID: 24723493
[TBL] [Abstract][Full Text] [Related]
35. Chronic lymphocytic leukemia and the skin: implications for the dermatologist.
Fried LJ; Criscito MC; Stevenson ML; Pomeranz MK
Int J Dermatol; 2022 May; 61(5):519-531. PubMed ID: 33951189
[TBL] [Abstract][Full Text] [Related]
36. Current and future treatment strategies in chronic lymphocytic leukemia.
Patel K; Pagel JM
J Hematol Oncol; 2021 Apr; 14(1):69. PubMed ID: 33902665
[TBL] [Abstract][Full Text] [Related]
37. Hematologist/oncologist disease-specific expertise and survival: lessons from chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL).
Shanafelt TD; Kay NE; Rabe KG; Inwards DJ; Zent CS; Leis JF; Schwager SM; Thompson CA; Bowen DA; Witzig TE; Slager SL; Call TG
Cancer; 2012 Apr; 118(7):1827-37. PubMed ID: 22009554
[TBL] [Abstract][Full Text] [Related]
38. Disease Flare During Temporary Interruption of Ibrutinib Therapy in Patients with Chronic Lymphocytic Leukemia.
Hampel PJ; Call TG; Rabe KG; Ding W; Muchtar E; Kenderian SS; Wang Y; Leis JF; Witzig TE; Koehler AB; Fonder AL; Schwager SM; Van Dyke DL; Braggio E; Slager SL; Kay NE; Parikh SA
Oncologist; 2020 Nov; 25(11):974-980. PubMed ID: 32886416
[TBL] [Abstract][Full Text] [Related]
39. COVID-19 in patients with chronic lymphocytic leukemia: a multicenter analysis by the Czech CLL study group.
Šimkovič M; Turcsányi P; Špaček M; Mihályová J; Ryznerová P; Maco M; Vodárek P; Écsiová D; Poul H; Móciková H; Zuchnická J; Panovská A; Lekaa M; Oršulová M; Prchlíková A; Stejskal L; Mašlejová S; Brychtová Y; Bezděková L; Papajík T; Lysák D; Trněný M; Smolej L; Doubek M
Ann Hematol; 2023 Apr; 102(4):811-817. PubMed ID: 36847805
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
